DCM Shriram

Q1 FY27Diversified

DCM Shriram Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book

Q1 FY27 earnings call: what management guided on revenue, margins and order book.

Price₹1,052

Market cap₹16.9K Cr

P/E12.3

Updated25 Aug 2026

Read4 min read

What the Q1 FY27 call signalled

3 of 5 strong

RevenueRank 3

MarginRank 3

CapexYes

FundraiseYes

Order bookYes

The short version

The company aims for consistent growth across all businesses except Urea and Cement, where no major expansion is planned. The company aims for consistent growth across all businesses except Urea and Cement.

From DCM Shriram's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Rank 3

The company aims for consistent growth across all businesses except Urea and Cement, where no major expansion is planned.
Focus on value-added chemical products like epichlorohydrin, hydrogen peroxide, epoxy, and aluminum chloride to drive growth.
Fenesta expects robust growth, despite some short-term impact from geopolitical issues; order book remains healthy (~INR 1,000 crore).
Shriram Farm Solutions targets growth via innovation, new products from in-house R&D, wider farmer reach, and digital marketing campaigns.
Bioseed business expects volume recovery contingent on monsoon; volumes were down due to delayed rains impacting sowing.
Sugar and ethanol volumes influenced by crop and market dynamics, with optimization between grain-based ethanol and sugar sales.
Overall, the management is optimistic about Indian economic growth and is leveraging digital technologies to boost productivity and customer engagement.

Profitability & Margins

The company aims for consistent growth across all businesses except Urea and Cement.
Focus on value-added chemical segments like epichlorohydrin, hydrogen peroxide, epoxy, and upcoming aluminum chloride to drive profitability.
Ongoing expansion and capacity utilization improvements, with new chemical plants (aluminum chloride, calcium chloride) commissioning in Q2 FY27.
Fenesta expects robust growth despite short-term volatility due to geopolitical factors.
Agriculture inputs like Shriram Farm Solutions to grow through R&D-driven new products and stronger farmer outreach, supporting margin expansion.
Fertilizer margins expected to be stable with improved energy efficiency; Urea business regulated with limited margin impact.
Bioseed impacted short-term by delayed monsoon but recovery expected with better monsoon conditions.
Digital technologies leveraged to enhance productivity and customer engagement.
Financial discipline maintained with debt-to-EBITDA targeted below 1.5 to preserve credit rating and support growth.
Overall, earnings and profitability are expected to improve supported by strong operational performance, new product launches, and market expansion.

See what DCM Shriram said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Yes

Two acquisitions totaling close to INR450 crore were made in the past year.
Capex of around INR1,000 crore was incurred recently.
No major new capex has been announced; ongoing capex is continuing as planned.
Net borrowing is expected to remain at similar levels due to ongoing capex.
Company aims to keep debt-to-EBITDA below 1.5 to maintain healthy financials.
Strategic investments include acquisition of an epoxy factory in Gujarat.
Fenesta business is setting up a facility to manufacture wooden doors, indicating new capital investment.
The company is actively working on demerger plans but without a clear timeline yet.
Commitment to renewable energy investment: sourcing 58 MW of hybrid renewable energy for Bharuch complex; peak renewable capacity expected to rise to 176 MW.

Fundraising & Capital Structure

No major new capex or fundraising through debt or equity has been announced for the current financial year.
Ongoing capex of around INR1,000 crore is being executed, but no significant new projects or expansions are currently planned.
Net borrowing is expected to remain around current levels with only a marginal reduction of about INR200 crore possible, depending on seasonal factors like the sugar season.
Debt to EBITDA is maintained prudently below 1.5 to ensure healthy financials and credit rating (AA+).
The company emphasizes financial discipline and is focused on operational excellence rather than raising fresh capital at this stage.

See what DCM Shriram said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Yes

Fenesta Building Systems has a healthy order book currently up by 4% year-on-year.
The total order book for Fenesta is close to INR 1,000 crore.
Growth in Fenesta's order intake was slightly lower than expected in the quarter, partly due to delays in decision-making linked to the West Asia crisis.
Despite fluctuations, Fenesta's management is confident about continued robust growth.
No specific figures on pending orders outside Fenesta were mentioned.

DCM Shriram — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹3.2K Cr, net profit ₹371 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What DCM Shriram Ltd's management said in earlier quarters

Compare:vs Godrej Industries Ltd vs 3M India Ltd vs Balmer Lawrie & Company Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were DCM Shriram Q1 FY27 results?

What is DCM Shriram share price analysis?

DCM Shriram currently shows a below-average growth signal. The stock trades at a P/E of 12.3 with a market cap of ₹16,875 Cr. Investors should review the full earnings analysis for detailed insights.

Is DCM Shriram planning capital expenditure?

Two acquisitions totaling close to INR450 crore were made in the past year.

Keep DCM Shriram on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.